I encourage researchers, clinicians, veterans and families and other members of the public to contribute their comments. FDA will consider their input when reviewing the proposed trials. We will also require transparency from the teams receiving these awards. Awardees will share research data with the drug development community while protecting patient privacy. This is a very unusual innovation. Most of the time that these trials take place, the information is proprietary and the drug companies do not share it in these trials. (14:23–14:30)
STATEMENT
Asserts that awardees must share research data while protecting patient privacy.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.